Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Generic Sweden

48.15 SEK

+2.88 %

Less than 1K followers

GENI

First North Stockholm

IT Services

Technology

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+2.88 %
+2.45 %
-5.77 %
-17.27 %
-12.45 %
-3.12 %
+30.66 %
+6.06 %
+103.21 %

Generic Sweden operates in the IT sector. The company offers a platform for digital communication services that are integrated into customers' internal or external communication flows. The services are provided through a CPaaS model (Communication Platform as a Service). The company's customers are found in several sectors with a particular position in alarms and security, healthcare and e-health, and e-commerce. The company was founded in 1993 and is headquartered in Stockholm.

Read more
Market cap
591.86M SEK
Turnover
909.18K SEK
Revenue
176.45M
EBIT %
18.88 %
P/E
21.69
Dividend yield-%
3.32 %
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
12/2
2026

Annual report '25

13/5
2026

Interim report Q1'26

13/5
2026

General meeting '26

All
Press releases
3rd party
ShowingAll content types
Regulatory press releaseyesterday

Generic Sweden AB: Generic välkomnar Jenny Björk som ny Chief Financial Officer

Generic Sweden
Third party research11/19/2025, 3:32 PM

Generic: Scaling efficiently for margin improvement - ABG

* Continued margin expansion driven by DOCS* EBIT estimates raised by 2-3% for '26e-'27e on scaling potential* Trading at 13x EV/EBIT, ~20% below its historical medianGrowing SaaS contributionGeneric reported a slightly better Q3, with sales of SEK 45m...

Generic Sweden
Third party research11/12/2025, 7:24 AM

Generic: Margin expansion driven by SaaS - ABG

* Sales +3% and adj. EBITA +14% vs ABGSCe* DOCS adoption >24% of municipalities* Consensus adj. EBIT likely up mid single-digits Q3'25 details Generic reports Q3'25 sales of SEK 45m (+3% vs. ABGSCe 44m), supported by new contracts and an improved product...

Generic Sweden

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release11/12/2025, 6:00 AM

Generic Sweden AB: Generic Sweden Delårsrapport Jan - Sept 2025

Generic Sweden
Third party research10/21/2025, 5:26 AM

Generic: Margin stability in a softer market - ABG

* Seasonally weaker volumes to weigh on earnings* 10-12% '26e-'27e sales growth, 21-22% EBIT margin* Trading at 12x EV/EBITA in '26e, ~15% below historical medianExpect usual seasonal impact on Q3 numbersGeneric reports its Q3'25 on 12 November, and ...

Generic Sweden
Regulatory press release9/25/2025, 8:00 AM

Generic Sweden AB: Generic stärker produktledning och teknikansvar

Generic Sweden
Third party research8/25/2025, 5:27 AM

Generic: Communication flows, margin grows - ABG

* Gross margin at 45% (40%)* SaaS supports margins and outlook* Trading at ~11-9x EV/EBITA for '26e-'27eStrong margin improvementGeneric reported sales of SEK 44m, up 2% y-o-y (4% below ABGSCe), driven by: i) lower volume-based products (e.g. SMS), which...

Generic Sweden
Third party research8/21/2025, 8:03 AM

Generic: Margins holding up well - ABG

* Sales -4% and adj. EBIT -11% vs ABGSCe* DOCS adoption >23% of municipalities* Consensus adj. EBIT likely down by mid single-digitsQ2'25 detailsGeneric reports Q2'25 sales of SEK 44.3m (-4% vs ABGSCe 46.2m), impacted by mix effects and smaller-sized...

Generic Sweden
Regulatory press release8/21/2025, 5:00 AM

Generic Sweden AB: Generic Sweden Delårsrapport Jan - Juni 2025

Generic Sweden
Third party research5/23/2025, 12:28 PM

Generic: Scalability on show - ABG

6% organic sales growth y-o-y SaaS momentum drives gross margin uplift... ... and leads to impressive EBIT growth of 41% y-o-y Q1: Sales growth of 6%, EBIT margin of 21.7% (16.3%) The Q1 report really showed the scalability of Generic's business model...

Generic Sweden
Regulatory press release5/15/2025, 4:30 PM

Generic Sweden AB - Kommuniké från årsstämman 15 maj 2025

Generic Sweden
Regulatory press release5/15/2025, 3:00 PM

Generic Sweden AB: Generic Sweden Delårsrapport Jan - Mars 2025

Generic Sweden
Press release5/15/2025, 2:20 PM

Helene Henriksson tillträder som VD och koncernchef i Generic Sweden AB

Generic Sweden
Regulatory press release5/8/2025, 2:30 PM

Komplettering av valberedningens förslag till årsstämman 2025 i Generic Sweden AB (publ)

Generic Sweden
Regulatory press release4/15/2025, 7:10 AM

Årsredovisning 2024 Generic Sweden AB

Generic Sweden
Regulatory press release4/15/2025, 7:00 AM

Kallelse till årsstämma 2025 Generic Sweden AB

Generic Sweden
Third party research2/18/2025, 10:48 AM

Generic: Ends 2024 in style - ABG

24% organic sales growth y-o-y Improved gross margin due to pricing and mix Opex flat y-o-y leads to 48% EBIT growth Q4: Sales growth of 24%, EBIT margin of 22.7% (19.0%) Generic continued its impressive comeback in Q4, where H1'24 profitability issues...

Generic Sweden
Regulatory press release2/13/2025, 6:00 AM

Bokslutskommuniké 2024 Generic Sweden AB

Generic Sweden
Regulatory press release2/5/2025, 9:00 AM

VD-byte i Generic Sweden AB

Generic Sweden
Third party research11/15/2024, 2:52 PM

Generic: Strong quarter and outlook - ABG

24% organic sales growth y-o-y Improved gross margin due to price adjustments Opex growth to abate in the coming quarters Q3: Sales growth of 24%, EBIT margin of 20.6% (22.6%) In our view, Generic's Q3 results were impressive. Sales growth remained strong...

Generic Sweden
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.